Lexi Ventures
www.lexi.vcLexi Ventures is a leading seed and pre-seed stage investor in US-based companies applying or enabling gene tech and synthetic biology, specifically those working with DNA, RNA, cells, and omics across health, consumer products, materials, and other sectors.
Is Lexi Ventures right for your startup?
Upload your pitch deck and get an AI-powered match score in minutes. See exactly how well you fit their investment criteria.
See If You're a MatchInvestment Thesis
Lexi Ventures believes genetic engineering is humanity’s most powerful technology, with the coming revolution in genetics applications offering more value creation potential than almost any other venture category. They focus on gene tech startups that aim to cure agonizing and expensive diseases while improving happiness and reducing healthcare needs, as well as enabling plants and microbes to produce newer and better things while sustaining the natural environment.
What Sets Them Apart
- Jonah Probell was a top-25 gene tech investor in 2024
- Deep technical expertise with founder, executive, and engineering roles in 7 startups, 2 IPOs, 16 granted patents
- Known for transparency, honesty, and contrarian thinking
- Patient approach to investing
- Seeks intentional diversification across multiple sectors (health, consumer, materials, etc.)
Sectors
Ready to find your perfect investor match?
Get Started Free